Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.
Our healthcare innovations address critical market gaps and offer transformative potential to wide range of indications including:
|Coronary Artery Bypass Graft Surgery||Pet Health||Chronic Kidney Disease|
Marizyme's products seek to dramatically improve some of the world’s most prevalent and costly healthcare challenges.
Marizyme seeks to leverage its full suite of biomedical assets to dramatically improve patient outcomes for some of the world’s most prevalent and costly healthcare challenges.
With one flagship product and multiple pipeline products and technologies, Marizyme presents opportunity while accounting for risk.
Led by a world-class management team, Marizyme continues to execute on its milestones and deliver both patient and shareholder value.